July 16, 2020
POP BIO announces $3M equity investment and JV with Eubiologics for the RSV vaccine development
POP BIO announces $3M investment and JV formation with Eubiologics for the development of an RSV vaccine POP Biotechnologies, Inc. (POP BIO), a preclinical stage biotechnology
Have any questions?
+61 383 766 284